Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Article
|
Electrophysiological phenotyping of left ventricular noncompaction cardiomyopathy in pediatric populations: A systematic reviewPhysiological reports, 2024-05, Vol.12 (9), p.e16029-n/a [Peer Reviewed Journal]2024 The Authors. published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society. ;2024 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society. ;2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2051-817X ;DOI: 10.14814/phy2.16029 ;PMID: 38684446Full text available |
|
22 |
Material Type: Newsletter Article
|
Australia : Government adds two new heart disease treatments on the PBSMENA Report, 20242022 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info). ;EISSN: 2219-0112Digital Resources/Online E-Resources |
|
23 |
Material Type: Article
|
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathyEuropean Heart Journal, 2023-11, Vol.44 (44)publicDigital Resources/Online E-Resources |
|
24 |
Material Type: Article
|
The effect of obesity and subsequent weight reduction on cardiac morphology and function in catsDigital Resources/Online E-Resources |
|
25 |
Material Type: Article
|
New Cardiomyopathy Guidelines Endorse Cardiac Myosin Inhibitors, Expanded Role for ExerciseHCPLive, 2024-05Copyright MultiMedia Healthcare Inc. 2024 ;ISSN: 2767-7168 ;EISSN: 2767-7168Digital Resources/Online E-Resources |
|
26 |
Material Type: Newsletter Article
|
Health Care Roundup: Market TalkDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 14, 2024Digital Resources/Online E-Resources |
|
27 |
Material Type: Newsletter Article
|
Health Care Roundup: Market TalkDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 14, 2024Digital Resources/Online E-Resources |
|
28 |
Material Type: Newsletter Article
|
Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)Business Wire, 2024Copyright Business Wire 2024Digital Resources/Online E-Resources |
|
29 |
Material Type: Newsletter Article
|
Press Release: Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 6, 2024Digital Resources/Online E-Resources |
|
30 |
Material Type: Newsletter Article
|
"We want to see if the defibrillator reduces the risk of sudden death in patients with cardiac scarring."CE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
31 |
Material Type: Newsletter Article
|
"Most arrhythmias can be treated with ablation."CE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
32 |
Material Type: Newsletter Article
|
Exercise, New Drug Class Recommended for Management of Hypertrophic CardiomyopathyTargeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |
|
33 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.25) drops 3.4% on increasing volatility; reports Loss of $32.2m; -15c [3.4%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 16, 2024Digital Resources/Online E-Resources |
|
34 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.39) inches higher, resistance at 12-day EMA; +11c [2.6%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 15, 2024Digital Resources/Online E-Resources |
|
35 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.28) lifts 1.9%; +8c [1.9%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 14, 2024Digital Resources/Online E-Resources |
|
36 |
Material Type: Newsletter Article
|
Weekly: Tenaya Therapeutics (TNYA: $4.20) tumbles 10% on weak volume; -48c [10.3%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 13, 2024Digital Resources/Online E-Resources |
|
37 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.20) tumbles 6.2%; -28c [6.2%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 11, 2024Digital Resources/Online E-Resources |
|
38 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.48) decreases; -3c [0.7%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 10, 2024Digital Resources/Online E-Resources |
|
39 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.51) falls 2.2%; -10c [2.2%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 9, 2024Digital Resources/Online E-Resources |
|
40 |
Material Type: Newsletter Article
|
Tenaya Therapeutics (TNYA: $4.61) lifts 1.5%; +7c [1.5%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 8, 2024Digital Resources/Online E-Resources |